Designing compounds that bias G-protein-coupled receptor (GPCR) signalling to preferentially activate either G-protein- or β-arrestin-mediated downstream signalling is an effective strategy to improve ...
Doctors have been diagnosing schizophrenia for more than a hundred years, but when it comes to treating this serious brain illness, the remedies still fall short. Sure, they can treat the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback